Catherine Moriarty
Papers
1
Total Citations
29
H-Index
1
About
Dr. Catherine Moriarty is a leading colorectal surgeon and clinical researcher whose work centers on improving surgical outcomes in rectal cancer, with a particular focus on preventing anastomotic leaks—a devastating complication. Her landmark contribution is the IntAct trial, a randomized controlled trial investigating intraoperative fluorescence angiography with indocyanine green (ICG) to assess bowel perfusion during rectal cancer surgery. This unblinded study, published in 2025 and already garnering 29 citations, directly addressed conflicting data on ICG’s efficacy, providing critical evidence on its safety and potential to reduce leak rates. Beyond this trial, Dr. Moriarty’s research integrates advanced intraoperative imaging with rigorous clinical trial design, bridging the gap between surgical innovation and patient safety. Her work has shaped protocols in colorectal units worldwide, and she is recognized for translating complex surgical technologies into practical, life-saving interventions. With a growing citation impact and a reputation for high-stakes clinical research, Dr. Moriarty is a pivotal figure in modern colorectal surgery, inspiring trainees and peers alike to pursue evidence-based improvements in operative care.
Research Focus
Key Achievements
Top Papers
- 1